ASCO 2020: Breast cancer roundup

FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma

Perioperative novel systemic immunotherapy-based approaches in urinary cancers

Highlights from ASCO 2020

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

Better genetic diagnostics in Ugandan breast cancer patients

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

Update from KAITLIN for high-risk HER2-positive early breast cancer

Brigatinib for NSCLC, latest research and overcoming complications

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19